Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Net Income towards Common Stockholders (2019 - 2025)

Volitionrx's Net Income towards Common Stockholders history spans 9 years, with the latest figure at $260595.0 for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 104.5% year-over-year to $260595.0; the TTM value through Dec 2025 reached -$5.3 million, up 80.49%, while the annual FY2025 figure was $146302.0, 100.54% up from the prior year.
  • Net Income towards Common Stockholders reached $260595.0 in Q4 2025 per VNRX's latest filing, up from -$31433.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $260595.0 in Q4 2025 to a low of -$9.5 million in Q2 2023.
  • Average Net Income towards Common Stockholders over 5 years is -$3.4 million, with a median of -$11004.5 recorded in 2021.
  • Peak YoY movement for Net Income towards Common Stockholders: soared 791.1% in 2022, then plummeted 12177.49% in 2023.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $73088.0 in 2021, then grew by 28.74% to $94092.0 in 2022, then crashed by 9344.41% to -$8.7 million in 2023, then soared by 33.4% to -$5.8 million in 2024, then surged by 104.5% to $260595.0 in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Net Income towards Common Stockholders are $260595.0 (Q4 2025), -$31433.0 (Q3 2025), and $29992.0 (Q2 2025).